Immitra Bio, a Zürich-based #genetic #medicine platform bringing scalability and commercial viability to #gene #editing #therapies, has announced the completion...
Immitra Bio, a Zürich-based #genetic#medicine platform bringing scalability and commercial viability to #gene#editing#therapies, has announced the completion of an upsized €2.58 million pre-Seed #financing round. 🇨🇭🧬🔬
